Mycobacterium haemophilum in an immunosuppressed child.
Mycobacterium haemophilum is an emerging cutaneous and systemic pathogen in immunosuppressed adults. Reports in the pediatric literature prior to 2004, limited to immunocompetent children with lymphadenitis, offer a different clinical presentation from that of the immunosuppressed adult. We report an instance of this atypical mycobacterial infection occurring in an immunosuppressed boy with clinical findings similar to those described in immunosuppressed adults.
Campbell
Lisa B
LB
Department of Dermatology, Geisinger Medical Centre, Danville, Pennsylvania 17822, USA.
Maroon
Michele
M
Pride
Howard
H
Adams
David C
DC
Tyler
William B
WB
D000293:Adolescent; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D009164:Mycobacterium Infections / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D018393:Mycobacterium haemophilum; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus